Skip to content

Feasibility study on the tumorectomy after neoadjuvant chemotherapy in stage IVb endometrial cancer

Feasibility study on the tumorectomy after neoadjuvant chemotherapy in stage IVb endometrial cancer - Feasibility study on the tumorectomy after NAC in stage IVb endometrial cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000012805
Enrollment
50
Registered
2014-01-10
Start date
2014-01-10
Completion date
Unknown
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stage IVb endometrial cancer

Interventions

neoadjuvant chemotherapy -&gt
surgery -&gt

Sponsors

Japanese Gynecologic Oncology Group
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: 1) Cases with a possibility of Primary cancer in other organs such as Cervical cancer or Ovarian cancer by diagnostic imaging 2) Patients with symptoms of brain metastases and bone marrow metastasis 3) Patients with active infection 4) Serious complications (heart disease, uncontrolled diabetes mellitus, malignant hypertension and tendency to bleeding) 5) Patients who have a synchronous malignancy or who have been progression-free less than 5 years for a metachronous malignancy 6) Patients with any signs of interstitial pneumonia or pulmonary fibrosis by chest radiography and CT 7) Massive pleural effusion or ascites 8) Neuropathy grade 3 or more (NCI-CTC) 9) Edema grade 3 or more (NCI-CTC) 10) Patients who have had a hypersensitivity reaction to polyoxyethylated or hydrogenated castor oil 11) Patients judged inappropriate for this study by the physicians

Design outcomes

Primary

MeasureTime frame
surgical operation ratio

Countries

Japan

Contacts

Public ContactToru Nakanishi, M.D.

JGOG2046 Coordinating Office Tohoku Medical and Pharmaceutical University Hospital

jgog2046@jgog.gr.jp022-259-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026